The Traderszone Network

Published in TZ Latest News 1 May, 2015 by The TZ Newswire Staff

Gilead Sciences, Inc. Earnings: Hepatitis C Market by the Numbers

Gilead posts a solid quarter boosted by its hepatitis C franchise.